Stock Screener App

Gratuito -

Installare

Drug Manufacturers - Specialty & Generic

26.46

1.34% -0.32

after-market

Dopo l'orario di chiusura: 26.46

Amphastar Pharmaceuticals Inc (AMPH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché AMPH Giù? Forum Previsione

Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie

Amphastar Pharmaceuticals Inc Stock Analysis and ForecastVolatility Index Analysis & Swing Trade Smarter With Data Insights - earlytimes.in

Will Amphastar Pharmaceuticals Inc. stock split again soonStock Screening Results & Make Confident Moves With Forecasting Models - bollywoodhelpline.com

Is Amphastar Pharmaceuticals Inc stock affected by interest rate hikesShort Setup & Reliable Intraday Trade Alerts - moha.gov.vn

How supply chain issues affect Amphastar Pharmaceuticals Inc. stockInstitutional Holding Changes & Minimal Investment Portfolio - bollywoodhelpline.com

Responsive Playbooks and the AMPH Inflection - Stock Traders Daily

Amphastar Director Sells 16,679 Shares for $441,800 - AOL.com

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

129,339 Shares in Amphastar Pharmaceuticals, Inc. $AMPH Purchased by Rice Hall James & Associates LLC - MarketBeat

Squarepoint Ops LLC Lowers Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

How Investors Are Reacting To Amphastar Pharmaceuticals (AMPH) Teriparatide Pen Approval And Insider Stock Sale - Sahm

Amphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call - MSN

A Fresh Look at Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Stabilisation - Sahm

Will Amphastar Pharmaceuticals Inc. stock outperform international peersJuly 2025 Review & Community Trade Idea Sharing Platform - Улправда

Can Amphastar’s Recent Rebound Signal a Compelling Opportunity in 2025? - Sahm

Is Amphastar Pharmaceuticals Inc. (29A) stock dividend growth reliable2025 AllTime Highs & High Conviction Buy Zone Alerts - Улправда

Why Amphastar Pharmaceuticals Inc. (29A) stock could be top winnerJuly 2025 Price Swings & Weekly Stock Breakout Alerts - Улправда

Why retail investors favor Amphastar Pharmaceuticals Inc. stockTreasury Yields & Daily Entry Point Trade Alerts - Улправда

How strong is Amphastar Pharmaceuticals Inc. stock revenue growthEarnings Performance Report & Free Verified High Yield Trade Plans - Улправда

Is Amphastar Pharmaceuticals Inc. stock a smart buy before Fed meetingQuarterly Portfolio Review & Weekly Watchlist of Top Performers - DonanımHaber

Will Amphastar Pharmaceuticals Inc. stock benefit from AI adoption2025 Key Lessons & Real-Time Volume Spike Alerts - DonanımHaber

Is Amphastar Pharmaceuticals Inc. stock a buy for dividend growthJuly 2025 Chart Watch & AI Based Buy/Sell Signal Reports - DonanımHaber

Geopolitics Watch: Will Amphastar Pharmaceuticals Inc. stock outperform international peersJuly 2025 Closing Moves & Weekly Market Pulse Updates - Улправда

Growth Review: Is Amphastar Pharmaceuticals Inc. (29A) stock dividend growth reliable2025 Volatility Report & Weekly Watchlist for Consistent Profits - Улправда

Insider Selling: Amphastar Pharmaceuticals (NASDAQ:AMPH) EVP Sells 9,787 Shares of Stock - MarketBeat

Risk Analysis: Why retail investors favor Amphastar Pharmaceuticals Inc. stockTrade Exit Report & Reliable Breakout Forecasts - Улправда

Will Amphastar Pharmaceuticals Inc. (29A) stock beat value stocksJuly 2025 Sector Moves & Free Fast Entry Momentum Trade Alerts - Улправда

Amphastar Pharmaceuticals Insider Sold Shares Worth $256,379, According to a Recent SEC Filing - marketscreener.com

Amphastar Pharmaceuticals Senior EVP Zhou Rong Sells Shares - TradingView — Track All Markets

Amphastar Pharmaceuticals (AMPH) executive logs option exercise and 9,787-share sale - Stock Titan

Rate Cut: Can Amphastar Pharmaceuticals Inc. stock withstand economic slowdownMarket Performance Summary & Stepwise Swing Trade Plans - Улправда

Amphastar reports FDA approval for teriparatide injection - MSN

Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative? - Yahoo Finance

Amphastar: Baqsimi Props Up Flat Growth, But 2026 Guidance Looks Fragile (NASDAQ:AMPH) - Seeking Alpha

Is FDA‑Cleared U.S.‑Made Teriparatide Pen Altering The Investment Case For Amphastar Pharmaceuticals (AMPH)? - simplywall.st

Amphastar Pharmaceuticals Director Makes Noteworthy Stock Sale - TipRanks

Insider Selling: Floyd Petersen Sells Shares of Amphastar Pharma - GuruFocus

Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells $44,623.53 in Stock - MarketBeat

Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells $62,881.92 in Stock - MarketBeat

Amphastar Pharmaceuticals Director Sells Over 4,000 Shares - TradingView — Track All Markets

Dir Petersen Sells 4,163 ($107.5K) Of Amphastar Pharmaceuticals Inc [AMPH] - TradingView — Track All Markets

Amphastar Pharmaceuticals (AMPH) director discloses recent common stock sales - Stock Titan

Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Up 4.8%Still a Buy? - MarketBeat

Amphastar stock rises after FDA approval of teriparatide injection - Investing.com

Amphastar announces FDA approval for teriparatide injection - marketscreener.com

Amphastar Announces FDA Approval for Teriparatide Injection - ACCESS Newswire

What analysts say about Amphastar Pharmaceuticals Inc 29A stockTechnical Pattern Recognition & Access Free Tools and Start Investing - earlytimes.in

Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Its Recent Share Price Slide - Sahm

Dir Petersen Files To Sell 4,163 Of Amphastar Pharmaceuticals Inc [AMPH] - TradingView — Track All Markets

Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded to "Hold" at Barclays - MarketBeat

Is Amphastar Pharmaceuticals Mispriced After a Tough Year and Promising Cash Flow Outlook in 2025? - Sahm

Barclays Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Equal-Weight Recommendation - Nasdaq

Amphastar Pharmaceuticals Breaks Below 200-Day Moving AverageNotable for AMPH - Nasdaq

Amphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated by Analysts at Barclays - MarketBeat

Barclays Initiates Amphastar Pharmaceuticals at Equalweight With $30 Price Target - marketscreener.com

Marshall Wace LLP Sells 183,037 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Falls 5.2% in Past Week as One-year Earnings and Shareholder Returns Continue Downward Trend - 富途牛牛

American Century Companies Inc. Sells 74,832 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Is Amphastar Pharmaceuticals Stock Built to Withstand a Pullback? - Trefis

Amphastar Pharmaceuticals, Inc. $AMPH Shares Bought by Quantbot Technologies LP - MarketBeat

RGC

$20.54

2.19%

ELAN

$22.52

0.49%

RDY

$13.86

1.28%

NBIX

$140.60

0.87%

VTRS

$12.46

0.08%

UTHR

$496.72

1.87%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters